Drug Trial Radar · NCT01376349
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Last checked: Nov 20, 2026Latest source record: Feb 7, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
464
Actual
Start
Jul 2011
Primary completion
Aug 2013
Study completion Nov 2017
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI); Mayo Clinic
- First posted
- Jun 20, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Supportive care
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Dehydroepiandrosterone (DHEA) may help relieve vaginal symptoms in female cancer survivors. PURPOSE: This randomized phase III trial studies DHEA to see how well it works compared to placebo in treating postmenopausal cancer survivors with vaginal symptoms.
Conditions
- Breast Cancer
- Gynecologic Cancer
Interventions
prasteroneDrug
Applied vaginally
placeboOther
Applied vaginally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Alleviation of the Most Bothersome Vaginal Symptom (Vaginal Dryness or Dyspareunia) Over 12 WeeksTime frame: At baseline and 12 weeks
Locations
280 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Scottsdale
Scottsdale, Arizona
Aurora Presbyterian Hospital
Aurora, Colorado
Boulder Community Hospital
Boulder, Colorado
Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado
St. Anthony Central Hospital
Denver, Colorado
Porter Adventist Hospital
Denver, Colorado
Presbyterian - St. Luke's Medical Center
Denver, Colorado
St. Joseph Hospital
Denver, Colorado
Rose Medical Center
Denver, Colorado
CCOP - Colorado Cancer Research Program
Denver, Colorado
Swedish Medical Center
Englewood, Colorado
Poudre Valley Hospital
Fort Collins, Colorado
Front Range Cancer Specialists
Fort Collins, Colorado
North Colorado Medical Center
Greeley, Colorado
Littleton Adventist Hospital
Littleton, Colorado
Sky Ridge Medical Center
Lone Tree, Colorado
Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado
McKee Medical Center
Loveland, Colorado
Parker Adventist Hospital
Parker, Colorado
St. Mary - Corwin Regional Medical Center
Pueblo, Colorado
North Suburban Medical Center
Thornton, Colorado
Exempla Lutheran Medical Center
Wheat Ridge, Colorado
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut
Herbert D. Kerman Regional Oncology Center - Daytona Beach
Daytona Beach, Florida
University of Florida Shands Cancer Center
Gainesville, Florida
Mayo Clinic - Jacksonville
Jacksonville, Florida
Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii
Cancer Research Center of Hawaii
Honolulu, Hawaii
OnCare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii
Queen's Cancer Institute at Queen's Medical Center
Honolulu, Hawaii
Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii
Hawaii Medical Center - East
Honolulu, Hawaii
OnCare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii
Castle Medical Center
Kailua, Hawaii
Kauai Medical Clinic
Lihue, Hawaii
Maui Memorial Medical Center
Wailuku, Hawaii
Pacific Cancer Institute - Maui
Wailuku, Hawaii
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho
Idaho Urologic Institute, PA
Meridian, Idaho
Showing 40 of 280 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.